Angola vs Chad: Antiretroviral therapy coverage for PMTCT
Angola
79.0%
in 2024
Chad
77.0%
in 2024
Angola rank
43rd
Chad rank
46th
Antiretroviral therapy coverage for PMTCT over time
- Angola
- Chad
How they compare
Angola currently reports 79.0% against 77.0% in Chad, a difference of 2.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Chad ahead.
Angola ranks 43rd and Chad ranks 46th of 84 countries.
Across the 3 decades both report, Angola averaged higher in 1 and Chad in 2.
Head to head by decade
| Decade | Angola | Chad | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.5% | 2.6% | 1.9% | Angola |
| 2010s | 25.0% | 51.0% | 26.0% | Chad |
| 2020s | 69.0% | 80.0% | 11.0% | Chad |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher antiretroviral therapy coverage for pmtct, Angola or Chad?
- Angola, at 79.0% against 77.0% in Chad as of 2024.
- What is the difference in antiretroviral therapy coverage for pmtct between Angola and Chad?
- 2.0%, with Angola ahead.
- How many years of comparable data are there for Angola and Chad?
- 25 years are reported by both, from 2000 to 2024.
- How do Angola and Chad rank globally for antiretroviral therapy coverage for pmtct?
- Angola ranks 43rd and Chad ranks 46th of 84 countries.
- Where does this data come from?
- UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).